Get the free PP-18 Use & Disclosure of Protected Health Information for Research - depts washington

This document outlines the policies and procedures for the use and disclosure of Protected Health Information (PHI) in research conducted at the University of Washington, detailing the necessary approvals

How to fill out pp-18 use disclosure of

How to fill out PP-18 Use & Disclosure of Protected Health Information for Research

1. Obtain a copy of the PP-18 form from the relevant authority or institution.
2. Read the instructions and guidelines provided with the form carefully.
3. Fill out the top section with your personal details, including name, contact information, and affiliation.
4. Indicate the purpose of the research and how you intend to use the protected health information.
5. Specify the type of data you will be accessing and any identifiers associated with it.
6. Describe how you will protect the confidentiality and security of the protected health information.
7. Include details on how long you will keep the information and your plan for its disposal after the research is complete.
8. Review the completed form for accuracy and completeness before submission.
9. Submit the form to the appropriate review board or authority for approval.

Who needs PP-18 Use & Disclosure of Protected Health Information for Research?

1. Researchers conducting studies that involve the use of protected health information.
2. Institutional review boards (IRBs) that need to ensure compliance with health privacy laws.
3. Organizations handling research data that requires safeguarding personal health information.

People Also Ask about

What are PHI 18 identifiers?

What are the 18 HIPAA Identifiers? The 18 HIPAA identifiers are the identifiers that must be removed from a designated record set before any remaining health information is considered to be de-identified under the “safe harbor” method of de-identification (see §164.514).

What does it mean to use protected health information?

ing to the Health Insurance Portability and Accountability Act (HIPAA), protected health information (PHI) is any health information that can identify an individual that is in possession of or transmitted by a "covered entity" or its business associates that relates to a patient's past, present, or future health.

What is the Hipaa policy for research?

Under the HIPAA Privacy Rule, covered entities may use or disclose protected health information from existing databases or repositories for research purposes either with individual authorization as required at 45 CFR 164.508, or with a waiver of individual authorization as permitted at 45 CFR 164.512(i).

When can I use or disclose protected health information (PHI)?

Covered entities may disclose protected health information that they believe is necessary to prevent or lessen a serious and imminent threat to a person or the public, when such disclosure is made to someone they believe can prevent or lessen the threat (including the target of the threat).

How many PHI indicators are there?

HIPAA PHI: Definition of PHI and List of 18 Identifiers.

What are the 18 identifiers for PHI?

The 18 HIPAA Identifiers Name. Address (all geographic subdivisions smaller than state, including street address, city county, and zip code) All elements (except years) of dates related to an individual (including birthdate, admission date, discharge date, date of death, and exact age if over 89) Telephone numbers.

What are the identifiers for PII?

PII might consist of direct identifiers, such as the name, social security number or other information that is unique to an individual, or indirect identifiers. Indirect identifiers include uncommon race, ethnicity, extreme age, unusual occupation and other details.

Are biometric identifiers PHI?

It is considered protected health information (PHI) when biometric identifiers like fingerprints or facial recognition are used in healthcare for patient identification or EHR access - subjecting it to HIPAA privacy and security regulations.

For pdfFiller’s FAQs

What is PP-18 Use & Disclosure of Protected Health Information for Research?

PP-18 Use & Disclosure of Protected Health Information for Research is a policy that outlines the guidelines and requirements for how protected health information (PHI) can be used and shared for research purposes, ensuring compliance with legal and ethical standards.

Who is required to file PP-18 Use & Disclosure of Protected Health Information for Research?

Researchers and organizations that intend to use protected health information for research purposes must file PP-18 to ensure proper authorization and compliance with regulations.

How to fill out PP-18 Use & Disclosure of Protected Health Information for Research?

To fill out PP-18, individuals should provide details about the research project, the type of PHI to be used, the purpose of the research, and obtain necessary approvals from ethics review boards or institutional review boards (IRBs).

What is the purpose of PP-18 Use & Disclosure of Protected Health Information for Research?

The purpose of PP-18 is to protect the privacy of individuals while allowing researchers to access necessary health information to advance medical knowledge and improve patient care through ethical research practices.

What information must be reported on PP-18 Use & Disclosure of Protected Health Information for Research?

The information that must be reported on PP-18 includes the scope of the research, specific types of PHI requested, justification for the use of PHI, how the information will be safeguarded, and any anticipated risks to privacy.